Philippe Albert - Alterola Biotech Insider

Alterola Biotech Inc -- USA Stock  

USD 1.25  0.30  19.35%

Deputy CEO of Altarea France

Mr. Albert Malaquin is Deputy Chief Executive Officer of Altarea France at Altarea SCA. He is also a Member of the Company Strategy Committee.

Management Efficiency

The company has return on total asset (ROA) of (133.34) % which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech Inc has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Found 2 records

CEO Since

Glenn FogelBooking Holdings Inc
Gillian TansBooking Holdings Inc

Entity Summary

Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech is traded on OTC Market in USA.Alterola Biotech Inc (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.

Did you try this?

Run Fundamental Analysis Now

Fundamental Analysis

View fundamental data based on most recent published financial statements
Hide  View All  NextLaunch Fundamental Analysis
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Alterola Biotech Inc to your portfolio

Top Management

Alterola Biotech Inc Leadership Team

Stock Performance

Alterola Biotech Performance Indicators